Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
A1 Receptor
24%
Atherosclerotic Cardiovascular Disease (ASCVD)
14%
Behavior Change
18%
Body Mass Index
15%
Built Environment
11%
Cardiovascular Disease
33%
Cardiovascular Prevention
33%
Cardiovascular Risk
10%
Collaborative Goal Setting
11%
Community Clinics
19%
Community Health Workers
70%
Department of Veterans Affairs
11%
Depressive Symptoms
14%
Diabetes
53%
Diabetes Education
10%
Diabetes Group Visits
18%
Diabetes Management
18%
Diabetes Medications
11%
European Society of Cardiology
11%
GLP-1 Receptor Agonist
12%
Glucagon-like
24%
Glycemic Control
14%
Group Visits
12%
Healthcare Professionals
30%
Hemoglobin A1c (HbA1c)
34%
Hispanic
15%
Intensive Lifestyle Intervention
16%
Kenyan
11%
Latino
13%
Lifestyle Medicine
11%
Low-income
28%
Low-income Settings
13%
Medication Access
12%
Obesity
10%
Oral Hypoglycemic Agents
11%
Patient Empowerment
12%
Patient Health Questionnaire-9 (PHQ-9)
11%
Physical Activity
11%
Prevention Studies
22%
Prevention Study
11%
Randomized Clinical Trial
25%
Receptor Agonist
24%
Scientific Sessions
15%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
15%
Statin Therapy
13%
Telehealth
25%
Type 2 Diabetes Mellitus (T2DM)
46%
United States
19%
Usual Care
20%
Weight Loss
11%
Medicine and Dentistry
Arm
9%
Arteriosclerotic Heart Disease
19%
Atherosclerosis
11%
Awareness
10%
Behavioral Change
7%
Blood Pressure
16%
Body Mass Index
12%
Cardiology
17%
Cardiovascular Disease
33%
Cardiovascular Disease Prevention
39%
Cardiovascular System
27%
Clinical Study
5%
Clinician
16%
Cohort Analysis
5%
Community Health
48%
Cotransporter
5%
Diabetes
100%
Diabetes Mellitus
6%
Disease Management
6%
Diseases
15%
Drug Therapy
5%
Glucagon-Like Peptide-1 Agonist
28%
Glycemic Control
7%
Health Care
13%
Health Care Cost
10%
Health Care Personnel
64%
Hemoglobin A1c
38%
Hypoglycemia
7%
Lifestyle Intervention
19%
Lifestyle Medicine
11%
Lipoprotein
7%
Low Density Lipoprotein Cholesterol
9%
Low Income Population
9%
Maturity Onset Diabetes of the Young
43%
Mobile Health
8%
Mortality Rate
6%
Nutrition
16%
Oral
14%
Pancreatitis
7%
Patient Health Questionnaire 9
12%
Physical Activity
12%
Prevalence
15%
Quality of Life
9%
Randomized Clinical Trials
16%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Sodium-Glucose Cotransporter 2 Inhibitors
10%
Statin
15%
Systematic Review
11%
Telehealth
20%
Veterans Affairs
12%